100 related articles for article (PubMed ID: 9230197)
1. Retinoids suppress epidermal growth factor-induced transcription of cyclooxygenase-2 in human oral squamous carcinoma cells.
Mestre JR; Subbaramaiah K; Sacks PG; Schantz SP; Tanabe T; Inoue H; Dannenberg AJ
Cancer Res; 1997 Jul; 57(14):2890-5. PubMed ID: 9230197
[TBL] [Abstract][Full Text] [Related]
2. Retinoids suppress phorbol ester-mediated induction of cyclooxygenase-2.
Mestre JR; Subbaramaiah K; Sacks PG; Schantz SP; Tanabe T; Inoue H; Dannenberg AJ
Cancer Res; 1997 Mar; 57(6):1081-5. PubMed ID: 9067275
[TBL] [Abstract][Full Text] [Related]
3. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
Han S; Inoue H; Flowers LC; Sidell N
Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 is overexpressed in human cervical cancer.
Kulkarni S; Rader JS; Zhang F; Liapis H; Koki AT; Masferrer JL; Subbaramaiah K; Dannenberg AJ
Clin Cancer Res; 2001 Feb; 7(2):429-34. PubMed ID: 11234900
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor-induced cyclooxygenase-2 expression in oral squamous cell carcinoma cell lines is mediated through extracellular signal-regulated kinase 1/2 and p38 but is Src and nuclear factor-kappa B independent.
Husvik C; Bryne M; Halstensen TS
Eur J Oral Sci; 2009 Oct; 117(5):528-35. PubMed ID: 19758248
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor-induced cyclooxygenase-2 expression is mediated through phosphatidylinositol-3 kinase, not mitogen-activated protein/extracellular signal-regulated kinase kinase, in recurrent respiratory papillomas.
Wu R; Abramson AL; Shikowitz MJ; Dannenberg AJ; Steinberg BM
Clin Cancer Res; 2005 Sep; 11(17):6155-61. PubMed ID: 16144915
[TBL] [Abstract][Full Text] [Related]
7. Ursolic acid inhibits cyclooxygenase-2 transcription in human mammary epithelial cells.
Subbaramaiah K; Michaluart P; Sporn MB; Dannenberg AJ
Cancer Res; 2000 May; 60(9):2399-404. PubMed ID: 10811116
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2 induction and prostaglandin E2 accumulation in squamous cell carcinoma as a consequence of epidermal growth factor receptor activation by imatinib mesylate.
Johnson FM; Yang P; Newman RA; Donato NJ
J Exp Ther Oncol; 2004 Dec; 4(4):317-25. PubMed ID: 15844661
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation.
Michaluart P; Masferrer JL; Carothers AM; Subbaramaiah K; Zweifel BS; Koboldt C; Mestre JR; Grunberger D; Sacks PG; Tanabe T; Dannenberg AJ
Cancer Res; 1999 May; 59(10):2347-52. PubMed ID: 10344742
[TBL] [Abstract][Full Text] [Related]
11. Essential role of c-Jun induction and coactivator p300 in epidermal growth factor-induced gene expression of cyclooxygenase-2 in human epidermoid carcinoma A431 cells.
Chen LC; Chen BK; Chang JM; Chang WC
Biochim Biophys Acta; 2004 Jul; 1683(1-3):38-48. PubMed ID: 15238218
[TBL] [Abstract][Full Text] [Related]
12. Gastrin and EGF synergistically induce cyclooxygenase-2 expression in Swiss 3T3 fibroblasts that express the CCK2 receptor.
Slice LW; Hodikian R; Zhukova E
J Cell Physiol; 2003 Sep; 196(3):454-63. PubMed ID: 12891702
[TBL] [Abstract][Full Text] [Related]
13. Involvement of tyrosine kinases on cyclooxygenase expression and prostaglandin E2 production in human gingival fibroblasts stimulated with interleukin-1beta and epidermal growth factor.
Yucel-Lindberg T; Ahola H; Carlstedt-Duke J; Modéer T
Biochem Biophys Res Commun; 1999 Apr; 257(2):528-32. PubMed ID: 10198245
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cyclooxygenase-2 expression. An approach to preventing head and neck cancer.
Mestre JR; Chan G; Zhang F; Yang EK; Sacks PG; Boyle JO; Shah JP; Edelstein D; Subbaramaiah K; Dannenberg AJ
Ann N Y Acad Sci; 1999; 889():62-71. PubMed ID: 10668483
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
Grau R; Iñiguez MA; Fresno M
Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
[TBL] [Abstract][Full Text] [Related]
16. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis.
Minter HA; Eveson JW; Huntley S; Elder DJ; Hague A
Clin Cancer Res; 2003 May; 9(5):1885-97. PubMed ID: 12738747
[TBL] [Abstract][Full Text] [Related]
17. Molecular pathology of cyclooxygenase-2 in neoplasia.
Fosslien E
Ann Clin Lab Sci; 2000 Jan; 30(1):3-21. PubMed ID: 10678579
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional induction of cyclooxygenase-2 gene by okadaic acid inhibition of phosphatase activity in human chondrocytes: co-stimulation of AP-1 and CRE nuclear binding proteins.
Miller C; Zhang M; He Y; Zhao J; Pelletier JP; Martel-Pelletier J; Di Battista JA
J Cell Biochem; 1998 Jun; 69(4):392-413. PubMed ID: 9620167
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 is up-regulated by interleukin-1 beta in human colorectal cancer cells via multiple signaling pathways.
Liu W; Reinmuth N; Stoeltzing O; Parikh AA; Tellez C; Williams S; Jung YD; Fan F; Takeda A; Akagi M; Bar-Eli M; Gallick GE; Ellis LM
Cancer Res; 2003 Jul; 63(13):3632-6. PubMed ID: 12839952
[TBL] [Abstract][Full Text] [Related]
20. Levels of cyclooxygenase-2 are increased in the oral mucosa of smokers: evidence for the role of epidermal growth factor receptor and its ligands.
Moraitis D; Du B; De Lorenzo MS; Boyle JO; Weksler BB; Cohen EG; Carew JF; Altorki NK; Kopelovich L; Subbaramaiah K; Dannenberg AJ
Cancer Res; 2005 Jan; 65(2):664-70. PubMed ID: 15695412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
